STING1 and ovarian carcinoma: CX-5461 induces cytosolic DNA buildup and STING activation, initiating a type I interferon response. It has potential to enhance immune responses and sensitize chemoresistant ovarian cancer cells to immunotherapy when combined with checkpoint inhibitors.